Insight Capital Research & Management Inc. Acquires New Position in UnitedHealth Group Incorporated (UNH)

Insight Capital Research & Management Inc. acquired a new position in UnitedHealth Group Incorporated (NYSE:UNH) during the second quarter, according to its most recent 13F filing with the SEC. The firm acquired 15,121 shares of the healthcare conglomerate’s stock, valued at approximately $2,804,000. UnitedHealth Group accounts for approximately 1.6% of Insight Capital Research & Management Inc.’s portfolio, making the stock its 14th largest position.

Other large investors have also recently made changes to their positions in the company. Retirement Systems of Alabama increased its stake in shares of UnitedHealth Group by 2.5% in the first quarter. Retirement Systems of Alabama now owns 640,240 shares of the healthcare conglomerate’s stock worth $105,006,000 after buying an additional 15,403 shares during the last quarter. Honeywell International Inc. purchased a new stake in shares of UnitedHealth Group during the first quarter worth about $35,262,000. Baldwin Brothers Inc. MA increased its stake in shares of UnitedHealth Group by 20.7% in the first quarter. Baldwin Brothers Inc. MA now owns 1,249 shares of the healthcare conglomerate’s stock worth $205,000 after buying an additional 214 shares during the last quarter. Harwood Advisory Group LLC increased its stake in shares of UnitedHealth Group by 0.8% in the first quarter. Harwood Advisory Group LLC now owns 1,885 shares of the healthcare conglomerate’s stock worth $309,000 after buying an additional 15 shares during the last quarter. Finally, Mn Services Vermogensbeheer B.V. increased its stake in shares of UnitedHealth Group by 3.9% in the first quarter. Mn Services Vermogensbeheer B.V. now owns 25,730 shares of the healthcare conglomerate’s stock worth $3,946,000 after buying an additional 970 shares during the last quarter. Hedge funds and other institutional investors own 86.21% of the company’s stock.

UnitedHealth Group Incorporated (NYSE UNH) traded down 0.98% on Friday, reaching $190.82. 2,858,501 shares of the company’s stock traded hands. The firm has a market cap of $184.50 billion, a PE ratio of 22.92 and a beta of 0.64. UnitedHealth Group Incorporated has a 12 month low of $132.39 and a 12 month high of $196.04. The firm’s 50-day moving average is $190.49 and its 200 day moving average is $175.87.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, July 18th. The healthcare conglomerate reported $2.46 earnings per share for the quarter, beating analysts’ consensus estimates of $2.38 by $0.08. The firm had revenue of $50.05 billion during the quarter, compared to analyst estimates of $49.97 billion. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.32%. The business’s quarterly revenue was up 7.7% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.96 earnings per share. Equities analysts predict that UnitedHealth Group Incorporated will post $9.87 EPS for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 19th. Stockholders of record on Friday, September 8th will be paid a dividend of $0.75 per share. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.57%. The ex-dividend date of this dividend is Thursday, September 7th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 35.13%.

WARNING: This piece of content was originally published by Week Herald and is the property of of Week Herald. If you are viewing this piece of content on another publication, it was illegally stolen and republished in violation of US & international trademark & copyright legislation. The original version of this piece of content can be viewed at https://weekherald.com/2017/08/19/insight-capital-research-management-inc-acquires-new-position-in-unitedhealth-group-incorporated-unh.html.

A number of equities research analysts have issued reports on UNH shares. Vetr upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $179.00 price objective on the stock in a research note on Monday, May 15th. Zacks Investment Research upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $199.00 price target on the stock in a research note on Tuesday, May 30th. BidaskClub upgraded shares of UnitedHealth Group from a “buy” rating to a “strong-buy” rating in a research note on Saturday, July 8th. Morgan Stanley raised their price target on shares of UnitedHealth Group from $202.00 to $210.00 and gave the company an “overweight” rating in a research note on Wednesday, June 28th. Finally, Bank of America Corporation raised their price target on shares of UnitedHealth Group from $210.00 to $214.00 and gave the company a “buy” rating in a research note on Friday, July 14th. One equities research analyst has rated the stock with a hold rating and twenty-four have assigned a buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and an average target price of $203.41.

In other news, Director William C. Ballard, Jr. sold 5,000 shares of the stock in a transaction that occurred on Thursday, August 3rd. The stock was sold at an average price of $193.98, for a total transaction of $969,900.00. Following the completion of the sale, the director now owns 76,058 shares of the company’s stock, valued at $14,753,730.84. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Director Gail R. Wilensky sold 5,540 shares of the stock in a transaction that occurred on Friday, June 2nd. The shares were sold at an average price of $178.74, for a total value of $990,219.60. Following the sale, the director now directly owns 60,516 shares of the company’s stock, valued at approximately $10,816,629.84. The disclosure for this sale can be found here. In the last three months, insiders have sold 15,540 shares of company stock valued at $2,873,320. Insiders own 0.89% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply